Neuren Pharmaceuticals Limited(ASX:NEU) added to S&P/ASX 200 Index
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
21.9 AUD | +2.62% | +13.57% | -12.17% |
09/05 | Neuren Pharmaceuticals Partner Acadia Pharmaceuticals Posts US DAYBUE Sales of $75.9 Million | MT |
24/04 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.17% | 1.71B | |
+31.37% | 588B | |
-2.60% | 364B | |
+20.83% | 326B | |
+5.69% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+10.77% | 167B | |
+0.10% | 161B |
- Stock Market
- Equities
- NEU Stock
- News Neuren Pharmaceuticals Limited
- Neuren Pharmaceuticals Limited(ASX: NEU) added to S&P/ASX 200 Index